1799 related articles for article (PubMed ID: 11886323)
21. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
[TBL] [Abstract][Full Text] [Related]
22. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
Maron BJ; Maron MS
Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cardiomyopathy: infants, children, and adolescents.
Maskatia SA
Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
[TBL] [Abstract][Full Text] [Related]
24. [Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].
Colín Lizalde Lde J
Arch Cardiol Mex; 2003; 73 Suppl 1():S26-30. PubMed ID: 12966640
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
McLeod CJ; Ackerman MJ; Nishimura RA; Tajik AJ; Gersh BJ; Ommen SR
J Am Coll Cardiol; 2009 Jul; 54(3):229-33. PubMed ID: 19589435
[TBL] [Abstract][Full Text] [Related]
26. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
Maron BJ; Maron MS; Wigle ED; Braunwald E
J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
[TBL] [Abstract][Full Text] [Related]
27. Review of recent advances in the management of hypertrophic cardiomyopathy.
Cao Y; Zhang PY
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5207-5210. PubMed ID: 29228435
[TBL] [Abstract][Full Text] [Related]
28. Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy.
Maron BJ; Rowin EJ; Udelson JE; Maron MS
JACC Heart Fail; 2018 May; 6(5):353-363. PubMed ID: 29655822
[TBL] [Abstract][Full Text] [Related]
29. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis.
Cam FS; Güray M
Anadolu Kardiyol Derg; 2004 Dec; 4(4):327-30. PubMed ID: 15590362
[TBL] [Abstract][Full Text] [Related]
31. [Hypertrophic cardiomyopathy in 2013].
Giannakopoulos G; Frangos C
Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
[TBL] [Abstract][Full Text] [Related]
32. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
Reith S; Klues HG
Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
[TBL] [Abstract][Full Text] [Related]
33. The natural history of hypertrophic cardiomyopathy.
Autore C; Musumeci MB
Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L11-L14. PubMed ID: 33654461
[TBL] [Abstract][Full Text] [Related]
34. Clinical course of hypertrophic cardiomyopathy with survival to advanced age.
Maron BJ; Casey SA; Hauser RG; Aeppli DM
J Am Coll Cardiol; 2003 Sep; 42(5):882-8. PubMed ID: 12957437
[TBL] [Abstract][Full Text] [Related]
35. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
[TBL] [Abstract][Full Text] [Related]
36. The diagnosis and treatment of hypertrophic cardiomyopathy.
Prinz C; Farr M; Hering D; Horstkotte D; Faber L
Dtsch Arztebl Int; 2011 Apr; 108(13):209-15. PubMed ID: 21505608
[TBL] [Abstract][Full Text] [Related]
37. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic cardiomyopathy in childhood.
Maron BJ
Pediatr Clin North Am; 2004 Oct; 51(5):1305-46. PubMed ID: 15331286
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
Harris KM; Spirito P; Maron MS; Zenovich AG; Formisano F; Lesser JR; Mackey-Bojack S; Manning WJ; Udelson JE; Maron BJ
Circulation; 2006 Jul; 114(3):216-25. PubMed ID: 16831987
[TBL] [Abstract][Full Text] [Related]
40. Cardiopulmonary Exercise Testing in Athletes With Hypertrophic Cardiomyopathy.
Newman DB; Garmany R; Contreras AM; Bos JM; Johnson JN; Geske JB; Allison TG; Ommen SR; Ackerman MJ
Am J Cardiol; 2023 Feb; 189():49-55. PubMed ID: 36508762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
